“Shall we try this?”—When Dr. Andria Sarsi of Memorial Sloan Kettering Cancer Center told this to Nisha Varghese, she felt a ray of hope. Nisha became one of the first four patients in the world who was ready to experiment with a new experimental drug called dostarlimab to treat rectal cancer.
She was the only Indian among the 18 patients who were part of the treatment. Two years later, they have completely recovered from cancer.
“Dostarlimab was used once in three weeks for 6 months. And the results showed the tumor had vanished. Is it hiding somewhere inside? I asked the doctor in surprise. It was a miracle,” recalls Nisha. The doctor gave her the happy news that she had recovered from cancer.
Nisha shares this miraculous experience of recovering from cancer, which in turn gives hope to a lot of people who have lost their zest for life after getting cancer.
Sloan Kettering Cancer Center under the guidance of Dr. Andria Sarsi and Dr. Louis Alberto Dias Junior is planning to use the same drug to treat other kinds of cancer as well. They are planning to use the dostarlimab drug to treat cancer in the gastric, prostate, and pancreas soon. This therapy which avoids chemotherapy, surgery, and radiation uses immunotherapy for treatment. Dr Dias calls this Immuno Emblative Therapy.
